AAAAAA

   
Results: 1-25 | 26-50 | 51-73 |
Results: 51-73/73
UNTITLED
Authors: COLTON T JOHNSON T MACHIN D
Citation: T. Colton et al., UNTITLED, Statistics in medicine, 14(15), 1995, pp. 1613-1613
MENSTRUAL REGULATION BY MIFEPRISTONE PLUS PROSTAGLANDIN - RESULTS FROM A MULTICENTER TRIAL
Authors: NORMAN J THONG KJ ALZUGARAY MG HO PC PRETNARDAROVEC A RES P KOVACS L NEMETH G CHEN JK ZHU YH SWAHN ML SONG LJ WANG YJ VANLOOK PFA BELSEY EM BERNERSLEE N LAPERRIERE N VONHERTZEN H MACHIN D ALI M
Citation: J. Norman et al., MENSTRUAL REGULATION BY MIFEPRISTONE PLUS PROSTAGLANDIN - RESULTS FROM A MULTICENTER TRIAL, Human reproduction, 10(2), 1995, pp. 308-314
HYPERTHERMIA IN CANCER-TREATMENT
Authors: MACHIN D PARMAR MKB
Citation: D. Machin et Mkb. Parmar, HYPERTHERMIA IN CANCER-TREATMENT, Lancet, 345(8965), 1995, pp. 1635-1636
SAMPLE-SIZE - HOW MANY PATIENTS ARE NECESSARY
Authors: FAYERS PM MACHIN D
Citation: Pm. Fayers et D. Machin, SAMPLE-SIZE - HOW MANY PATIENTS ARE NECESSARY, British Journal of Cancer, 72(1), 1995, pp. 1-9
BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION
Authors: GRIEVE AP POCOCK SJ ABRAMS K ASHBY D HEALY MJR JENNISON C LEWIS JA LINDLEY DV MACHIN D NEWMAN GB BATHER JA BAILEY RA EVANS SJW KEIDING N MATTHEWS JNS GORE SM SENN S HERSON J TURNBULL BW ALTMAN DG ARMITAGE P ATKINSON AC BERRY DA BUYSE ME CARLIN BP DEMETS DL DEMPSTER AP DUNSTAN FDJ ELLENBERG SS FAYERS P GAIL MH GEORGE SL GREENHOUSE JB WASSERMAN LA HARRELL FE JOSEPH L SHAPIRO SH KADANE JB LEHMANN HP MARUBINI E MARIANI L PATER JL PETTIT LI YOUNG KDS ROSNER GL WHITEHEAD J WIEAND HS
Citation: Ap. Grieve et al., BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION, Journal of the Royal Statistical Society. Series A. Statistics in society, 157, 1994, pp. 387-416
APPROACHES TO THE ANALYSIS OF QUALITY-OF-LIFE DATA - EXPERIENCES GAINED FROM MEDICAL-RESEARCH-COUNCIL LUNG-CANCER WORKING PARTY PALLIATIVE CHEMOTHERAPY TRIAL
Authors: HOPWOOD P STEPHENS RJ MACHIN D
Citation: P. Hopwood et al., APPROACHES TO THE ANALYSIS OF QUALITY-OF-LIFE DATA - EXPERIENCES GAINED FROM MEDICAL-RESEARCH-COUNCIL LUNG-CANCER WORKING PARTY PALLIATIVE CHEMOTHERAPY TRIAL, Quality of life research, 3(5), 1994, pp. 339-352
COPING WITH EXTRA POISSON VARIABILITY IN THE ANALYSIS OF FACTORS INFLUENCING VAGINAL RING EXPULSIONS - REPLY
Authors: CAMPBELL MJ MACHIN D
Citation: Mj. Campbell et D. Machin, COPING WITH EXTRA POISSON VARIABILITY IN THE ANALYSIS OF FACTORS INFLUENCING VAGINAL RING EXPULSIONS - REPLY, Statistics in medicine, 13(8), 1994, pp. 875-876
PAPERS FROM THE INTERNATIONAL MEETINGS OF THE INTERNATIONAL-SOCIETY-FOR-CLINICAL-BIOSTATISTICS - PREFACE
Authors: COLTON T JOHNSON T MACHIN D
Citation: T. Colton et al., PAPERS FROM THE INTERNATIONAL MEETINGS OF THE INTERNATIONAL-SOCIETY-FOR-CLINICAL-BIOSTATISTICS - PREFACE, Statistics in medicine, 13(23-24), 1994, pp. 2389-2389
ON THE DEVELOPMENT OF THE MEDICAL-RESEARCH-COUNCIL TRIAL OF ALPHA-INTERFERON IN METASTATIC RENAL-CARCINOMA
Authors: FAYERS PM COOK PA MACHIN D DONALDSON N WHITEHEAD J RITCHIE A OLIVER RTD YUEN P
Citation: Pm. Fayers et al., ON THE DEVELOPMENT OF THE MEDICAL-RESEARCH-COUNCIL TRIAL OF ALPHA-INTERFERON IN METASTATIC RENAL-CARCINOMA, Statistics in medicine, 13(21), 1994, pp. 2249-2260
THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING - DISCUSSION
Authors: MACHIN D
Citation: D. Machin, THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING - DISCUSSION, Statistics in medicine, 13(13-14), 1994, pp. 1385-1389
STATISTICAL-METHODS FOR CLINICAL-TRIALS
Authors: BAILEY A CROOK A MACHIN D
Citation: A. Bailey et al., STATISTICAL-METHODS FOR CLINICAL-TRIALS, Blood reviews, 8(2), 1994, pp. 105-112
TREATMENT-RELATED DEATHS IN SMALL-CELL LUNG-CANCER TRIALS - CAN PATIENTS AT RISK BE IDENTIFIED
Authors: STEPHENS RJ GIRLING DJ MACHIN D THATCHER N BLEEHEN NM BOLGER JJ CLARK PI HASLETON PS HOPWOOD P MACBETH FR MOGHISSI K SAUNDERS MI WHITE RJ
Citation: Rj. Stephens et al., TREATMENT-RELATED DEATHS IN SMALL-CELL LUNG-CANCER TRIALS - CAN PATIENTS AT RISK BE IDENTIFIED, Lung cancer, 11(3-4), 1994, pp. 259-274
PATHOLOGY REVIEW AND DIAGNOSIS OF CANCER
Authors: MACHIN D PARMAR MKB
Citation: D. Machin et Mkb. Parmar, PATHOLOGY REVIEW AND DIAGNOSIS OF CANCER, Lancet, 343(8888), 1994, pp. 55-55
SURGICAL RESECTION FOR SMALL-CELL LUNG-CANCER
Authors: GIRLING DJ MACHIN D STEPHENS RJ
Citation: Dj. Girling et al., SURGICAL RESECTION FOR SMALL-CELL LUNG-CANCER, Thorax, 49(6), 1994, pp. 624-624
CAN LONG-TERM SURVIVAL BE IMPROVED IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND GOOD PERFORMANCE STATUS
Authors: BLEEHEN NM GIRLING DJ GREGOR A LEONARD RCF MACHIN D MCKENZIE CG MORGAN DAL SMYTH JF SPITTLE MF STEPHENS RJ YOSEF HMA BOLGER JJ CLARK PI HASLETON PS HOPWOOD P MACBETH FR MOGHISSI K SAUNDERS MI THATCHER N WHITE RJ
Citation: Nm. Bleehen et al., CAN LONG-TERM SURVIVAL BE IMPROVED IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND GOOD PERFORMANCE STATUS, British Journal of Cancer, 70(1), 1994, pp. 142-144
PAPERS FROM THE INTERNATIONAL-SOCIETY-FOR-CLINICAL-BIOSTATISTICS 13THINTERNATIONAL MEETING, AUGUST 1992 - PREFACE
Authors: COLTON T FREEDMAN L JOHNSON T MACHIN D
Citation: T. Colton et al., PAPERS FROM THE INTERNATIONAL-SOCIETY-FOR-CLINICAL-BIOSTATISTICS 13THINTERNATIONAL MEETING, AUGUST 1992 - PREFACE, Statistics in medicine, 12(24), 1993, pp. 2253-2253
STOPPING RULES, INTERIM ANALYSES AND DATA MONITORING COMMITTEES
Authors: ASHBY D MACHIN D
Citation: D. Ashby et D. Machin, STOPPING RULES, INTERIM ANALYSES AND DATA MONITORING COMMITTEES, British Journal of Cancer, 68(6), 1993, pp. 1047-1050
A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS
Authors: BLEEHEN NM GIRLING DJ MACHIN D STEPHENS RJ BARLEY VL BULLIMORE JA WHITE RJ BLEEHAN NM WILLIAMS MV BREDIN CP DAVIDSON AR WILLIAMS TJ ASH DV CLOSE HJ JOSLIN CA MUERS MF STONE J ASHFORD RF DISCHE S DUNPHY EP FERMONT DC GROSCH E MAHER EJ SAUNDERS MI ADAM RJ ALCOCK CJ BENSON MK HOPKIN JM LANE DJ HUNTER AM
Citation: Nm. Bleehen et al., A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS, British Journal of Cancer, 68(6), 1993, pp. 1150-1156
A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE
Authors: BLEEHEN NM GIRLING DJ MACHIN D STEPHENS RJ HARTLEY JPR HODSON NJ TURTON CW BARLEY VL BULLIMORE JA WHITE RJ BLEEHEN NM WILLIAMS MV BREDIN CP DAVIDSON AR WILLIAMS TJ ASH DV CLOSE HJ JOSLIN CA MUERS MF STONE J ASHFORD RF DISCHE S DUNPHY EP FERMONT DC GROSCH E MAHER EJ SAUNDERS MI ADAM RJ ALCOCK CJ BENSON MK HOPKIN JM LANE DJ HUNTER AM
Citation: Nm. Bleehen et al., A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE, British Journal of Cancer, 68(6), 1993, pp. 1157-1166
A SIMULATED SEQUENTIAL-ANALYSIS BASED ON DATA FROM 2 MRC TRIALS
Authors: DONALDSON AN WHITEHEAD J STEPHENS R MACHIN D
Citation: An. Donaldson et al., A SIMULATED SEQUENTIAL-ANALYSIS BASED ON DATA FROM 2 MRC TRIALS, British Journal of Cancer, 68(6), 1993, pp. 1171-1178
PATHOLOGY REVIEW IN CANCER-RESEARCH
Authors: FREEDMAN LS MACHIN D
Citation: Ls. Freedman et D. Machin, PATHOLOGY REVIEW IN CANCER-RESEARCH, British Journal of Cancer, 68(5), 1993, pp. 827-830
INTENTION TO TREAT - WHO SHOULD USE ITT
Authors: LEWIS JA MACHIN D
Citation: Ja. Lewis et D. Machin, INTENTION TO TREAT - WHO SHOULD USE ITT, British Journal of Cancer, 68(4), 1993, pp. 647-650
CURRENT STATISTICAL ISSUES IN CLINICAL CANCER-RESEARCH
Authors: ALTMAN DG MACHIN D
Citation: Dg. Altman et D. Machin, CURRENT STATISTICAL ISSUES IN CLINICAL CANCER-RESEARCH, British Journal of Cancer, 68(3), 1993, pp. 455-456
Risultati: 1-25 | 26-50 | 51-73 |